AfterJack Quaidbroke into prominence with his role as Hughie Campbell inThe Boys, he has found a niche in action roles. He first began his career as the District 1 tribute Marvel inThe Hunger Games. Despite appearing in a massive movie, Quaid’s role was relatively understated. He broke his nose shortly before filming and the producers did not even need to adjust the scripts.The Boysgave him the push he needed to become a major sensation within the industry. Since he first appeared as Hughie in 2019,Quaid’s extensive filmographyhas grown exponentially.
AfterThe Boysbegan, Quaid appeared in important roles inScream(2022),Oppenheimer(2023), andCompanion(2025). Outside his live-action roles, he is known for playing Boimler inStar Trek: Lower Decks, Superman inMy Adventures with Superman, and the Lizard inSpider-Man: Across The Spider-Verse(2023). All ofthese roles showed Quaid’s versatility, as he swung from a theoretical physicist to a hero to a remorseless monster without ever stumbling. Now, Quaid is starring in a critically renowned action movie.
Novocaine Has An Exceptional Tomatometer Score
Critics Love Quaid’s New Action Movie
Jack Quaid’sNovocaineis already proving to be a success among critics. As theNovocaineSuper Bowl trailer revealed, Quaid stars as Nathan Caine, a man without the ability to feel pain. After his girlfriend (Amber Midthunder) is taken hostage, Nathan is left with no choice but to rescue her. The movie isscheduled for a March 14 release. Dan Berk and Robert Olsen served as co-directors of the nearly two-hour-long film.
The action-packed movie has had a good showing on the review aggregatorRotten Tomatoes. At the time of writing, it maintains a92% Tomatometer score. This near-perfect total is based on 24 reviews withan average score of 7.0 out of 10. This is likely to change as more reviews come in, but it is certainly a positive sign for a movie that was based on an entirely new intellectual property. The next test of the movie’s quality is likely to be the Popcornmeter score, which is based on audience responses and will be revealed within the next week.
Our Take On Novocaine’s Rotten Tomatoes Success
This Is A Great Sign For Quaid
Quaid’s latest movie could easily prove to have long legs at the box office. It is unlikely that audiences will race to the theaters to watch an original movie, given that 2024 was such a franchise-heavy year. Still, if audiences see that critics have nothing but praise forNovocaine, they may be more willing to take a risk. If they do, it would be a perfect result for a movie thatScreenRant’s Rachel Labonte called “a rollicking adventure that… doesn’t really let up” in herNovocainereview. Labonte gave the movie an 8 out of 10 score for good reason.
The Tomatometer score is important, but its long-term prospects will depend on the Popcornmeter score.
Unsurprisingly,Quaid is the biggest draw of the movie. Most of the reviewers praised his performance, but the premise was also unique enough to intrigue the critics. If it earns enough attention from general audiences in its first week, it should obtain good word-of-mouth and a strong box office run. The Tomatometer score is important, but its long-term prospects will depend on the Popcornmeter score, which more directly pertains to audience interests. As audiences flock toNovocainethis week, they will decide the fate of Quaid’s latest action flick.
